Literature DB >> 19172988

The complex interaction between APOE promoter and AD: an Italian case-control study.

Alessandra Bizzarro1, Davide Seripa, Adele Acciarri, Maria Giovanna Matera, Alberto Pilotto, Francesco Danilo Tiziano, Christina Brahe, Carlo Masullo.   

Abstract

The single nucleotide polymorphisms (SNPs) rs449647, rs769446 and rs405509 in the promoter region of the APOE gene have been variously suggested to be epsilon 4-independent risk factors for Alzheimer's disease (AD). A previous Italian study found that the rs449647 was significantly associated with late-onset AD. The aim of this study was to verify whether these APOE promoter SNPs are genetic risk factors for AD and to investigate their interaction with the common APOE polymorphism. A total of 169 clinically diagnosed AD patients and 99 cognitively intact age-matched controls were included in the study. Significant associations with AD independent from sex, age and APOE/epsilon 4 status were found for rs449647 A/A and rs405509 G/G genotypes (positive), and rs449647 A/T and rs405509 T/T genotypes (negative). Haplotype frequency estimation at the APOE locus showed significant associations for the ATG4, ATT4 and ACG3 (positive) and ATT2, ATT3 and TCG3 (negative) haplotypes. Therefore this study confirms the role of the rs449647 A/A genotype as risk factor for AD in Italy and suggests that promoter genotypes and APOE haplotypes might have a complex function in AD-associated genetic risk factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172988      PMCID: PMC2986491          DOI: 10.1038/ejhg.2008.263

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  40 in total

1.  APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease.

Authors:  V M Casadei; C Ferri; F Veglia; A Gavazzi; G Salani; M Cattaneo; S Sorbi; G Annoni; F Licastro; C Mariani; M Franceschi; L M Grimaldi
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

2.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

Review 3.  Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease.

Authors:  M J Bullido; F Valdivieso
Journal:  Microsc Res Tech       Date:  2000-08-15       Impact factor: 2.769

4.  A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

Authors:  J C Lambert; F Pasquier; D Cottel; B Frigard; P Amouyel; M C Chartier-Harlin
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

5.  Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene.

Authors:  M J Artiga; M J Bullido; I Sastre; M Recuero; M A García; J Aldudo; J Vázquez; F Valdivieso
Journal:  FEBS Lett       Date:  1998-01-09       Impact factor: 4.124

6.  APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.

Authors:  L Zurutuza; P Verpillat; G Raux; D Hannequin; M Puel; S Belliard; A Michon; Y Pothin; A Camuzat; C Penet; C Martin; A Brice; D Campion; F Clerget-Darpoux; T Frebourg
Journal:  Eur J Hum Genet       Date:  2000-09       Impact factor: 4.246

7.  Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.

Authors:  J C Wang; J M Kwon; P Shah; J C Morris; A Goate
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

8.  Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE.

Authors:  Y Q Song; E Rogaeva; S Premkumar; N Brindle; T Kawarai; A Orlacchio; G Yu; G Levesque; M Nishimura; M Ikeda; Y Pei; C O'Toole; R Duara; W Barker; S Sorbi; M Freedman; L Farrer; P St George-Hyslop
Journal:  Neurosci Lett       Date:  1998-07-10       Impact factor: 3.046

9.  Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.

Authors:  J C Lambert; C Berr; F Pasquier; A Delacourte; B Frigard; D Cottel; J Pérez-Tur; V Mouroux; M Mohr; D Cécyre; D Galasko; C Lendon; J Poirier; J Hardy; D Mann; P Amouyel; M C Chartier-Harlin
Journal:  Hum Mol Genet       Date:  1998-09       Impact factor: 6.150

Review 10.  Apolipoprotein E genotyping in Alzheimer's disease. National Institute on Aging/Alzheimer's Association Working Group.

Authors: 
Journal:  Lancet       Date:  1996-04-20       Impact factor: 79.321

View more
  15 in total

1.  Inflammatory gene variants in the Tsimane, an indigenous Bolivian population with a high infectious load.

Authors:  Sarinnapha Vasunilashorn; Caleb E Finch; Eileen M Crimmins; Suvi A Vikman; Jonathan Stieglitz; Michael Gurven; Hillard Kaplan; Hooman Allayee
Journal:  Biodemography Soc Biol       Date:  2011

2.  Association between Alzheimer disease and the -491T allele of regulatory region polymorphism of Apolipoprotein E in a Tunisian population.

Authors:  Afef Achouri-Rassas; Sondes Hadj Fredj; Hela Mrabet Khiari; Amina Bibi; Hajer Siala; Amel Mrabet; Taieb Messaoud
Journal:  Neurochem Res       Date:  2013-12-11       Impact factor: 3.996

3.  Is there a significant interaction effect between apolipoprotein E rs405509 T/T and ε4 genotypes on cognitive impairment and gray matter volume?

Authors:  C Ma; Y Zhang; X Li; J Zhang; K Chen; Y Liang; Y Chen; Z Liu; Z Zhang
Journal:  Eur J Neurol       Date:  2016-06-04       Impact factor: 6.089

4.  APOE polymorphisms and cognitive functions in patients with brain tumors.

Authors:  Denise D Correa; Jaya Satagopan; Raymond E Baser; Kenneth Cheung; Elizabeth Richards; Michael Lin; Sasan Karimi; John Lyo; Lisa M DeAngelis; Irene Orlow
Journal:  Neurology       Date:  2014-06-18       Impact factor: 9.910

5.  Translating Mendelian and complex inheritance of Alzheimer's disease genes for predicting unique personal genome variants.

Authors:  Kelly Regan; Kanix Wang; Emily Doughty; Haiquan Li; Jianrong Li; Younghee Lee; Maricel G Kann; Yves A Lussier
Journal:  J Am Med Inform Assoc       Date:  2012 Mar-Apr       Impact factor: 4.497

6.  Association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimer's disease: A meta-analysis.

Authors:  Hanyan Xiao; Yifeng Gao; Lei Liu; Yan Li
Journal:  EXCLI J       Date:  2017-06-20       Impact factor: 4.068

7.  Effects of the association between APOE rs405509 polymorphisms and gene-environment interactions on hand grip strength among middle-aged and elderly people in a rural population in southern China.

Authors:  Haoyu He; Huaxiang Lu; Shuzhen Liu; Jiansheng Cai; Xu Tang; Chunbao Mo; Xia Xu; Quanhui Chen; Min Xu; Chuntao Nong; Qiumei Liu; Junling Zhang; Jian Qin; Zhiyong Zhang
Journal:  J Orthop Surg Res       Date:  2021-06-11       Impact factor: 2.359

8.  Influence of multiple APOE genetic variants on cognitive function in a cohort of older men - results from the Normative Aging Study.

Authors:  Diddier Prada; Elena Colicino; Melinda C Power; David G Cox; Marc G Weisskopf; Lifang Hou; Avron Spiro Iii; Pantel Vokonas; Jia Zhong; Marco Sanchez-Guerra; Luis A Herrera; Joel Schwartz; Andrea A Baccarelli
Journal:  BMC Psychiatry       Date:  2014-08-01       Impact factor: 3.630

9.  The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.

Authors:  Anna Limon-Sztencel; Beata S Lipska-Ziętkiewicz; Magdalena Chmara; Bartosz Wasag; Leszek Bidzan; Beata R Godlewska; Janusz Limon
Journal:  Alzheimers Res Ther       Date:  2016-05-19       Impact factor: 6.982

10.  Influence of genetic polymorphisms in homocysteine and lipid metabolism systems on antidepressant drug response.

Authors:  Baoyu Yuan; Xiaoyan Sun; Zhi Xu; Mengjia Pu; Yonggui Yuan; Zhijun Zhang
Journal:  BMC Psychiatry       Date:  2020-08-14       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.